Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 54 (HNRNPA1P54) is a **pseudogene**—a non-functional genomic DNA sequence similar to the functional HNRNPA1 gene, which encodes an RNA-binding protein involved in pre-mRNA processing and splicing[1][4][7]. Pseudogenes generally do not produce a functional protein due to disabling mutations or lack of transcription. HNRNPA1P54 itself is not known to have any biological function, disease association, or role as a therapeutic target; there are no reported interacting drugs, mechanisms of action, or biomarker utility[1][4][7]. Pseudogenes can occasionally have regulatory roles at the RNA level (e.g., as competing endogenous RNAs in some forms of cancer), but there is no documented evidence that HNRNPA1P54 has such a function[7]. Importantly, confusion often arises because its parent gene, HNRNPA1, is functionally significant in RNA metabolism, cell stress response, some cancers, and neurodegenerative diseases; this is not the case for the pseudogene HNRNPA1P54[2][3][6][8]. **Summary Interpretation:** - **HNRNPA1P54** is not a protein-coding gene, not a proven therapeutic target, and not associated with actionable functions or diseases. - The entry is arguably "incorrect" as a therapeutic target or receptor because it is a pseudogene, and any functional attributes pertain to HNRNPA1, not HNRNPA1P54[1][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 54 (HNRNPA1P54).